Organovo Says No to Tarveda Merger
BusinessOrganovo Says No to Tarveda MergerOrganovo Says No to Tarveda Merger
The San Diego, CA-based company originally made a move to merge with Tarveda Therapeutics late last year. Organovo considered the measure after it failed to generate decisive scientific data to support the prolonged functionality and therapeutic benefit of its liver tissue candidate and had to hit the reset button.
Sign up for the QMED & MD+DI Daily newsletter.